|
Phenotype Submission - Congenital Heart Disease
|
|
1
|
123
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with lung diseases and/or hypoxia (WHO Group 3)
|
|
2
|
174
|
September 16, 2023
|
|
Phenotype Submission - Pulmonary hypertension associated with left heart disease (WHO Group 2)
|
|
2
|
342
|
September 16, 2023
|
|
Phenotype Submission - Scleroderma
|
|
1
|
130
|
September 16, 2023
|
|
Phenotype Submission - Sickle Cell Anemia
|
|
1
|
126
|
September 16, 2023
|
|
Phenotype Submission - Sarcoidosis
|
|
1
|
154
|
September 16, 2023
|
|
Phenotype Submission - Right Heart Failure
|
|
1
|
159
|
September 16, 2023
|
|
Phenotype Submission - PAH Drug Treatment Groups
|
|
1
|
151
|
September 16, 2023
|
|
Phenotype Submission - PAH plus Left Heart Disease
|
|
1
|
114
|
September 16, 2023
|
|
Phenotype Submissions - HowOften - Dual biologic therapy for IBD, PsO, and PsA
|
|
1
|
133
|
September 16, 2023
|
|
Phenotype Submission - Non-infectious uveitis and iridocyclitis
|
|
1
|
168
|
September 15, 2023
|
|
Phenotype Submission - Down Syndrome
|
|
1
|
148
|
September 15, 2023
|
|
Phenotype Submission - Motor Vehicle Accidents (MVA)
|
|
1
|
214
|
September 15, 2023
|
|
Phenotype Submission - Pulmonary Arterial Hypertension (WHO Group 1)
|
|
1
|
178
|
September 14, 2023
|
|
Phenotype Submission - Pulmonary Hypertension
|
|
1
|
170
|
September 14, 2023
|
|
Phenotype submission - Diabetic ketoacidosis
|
|
1
|
166
|
September 8, 2023
|
|
Nested criteria interpretation
|
|
1
|
167
|
September 7, 2023
|
|
Call for collaboration - Myasthenia Gravis PROJECT
|
|
0
|
136
|
September 7, 2023
|
|
Characterization - defining treatment combinations
|
|
0
|
144
|
September 6, 2023
|
|
Characterization - subgroup analysis
|
|
0
|
128
|
September 6, 2023
|
|
Cohort pathways - collapse days
|
|
2
|
360
|
September 5, 2023
|
|
Visit type on index date
|
|
0
|
171
|
August 30, 2023
|
|
Location information in Atlas (Geography, State)
|
|
4
|
279
|
August 28, 2023
|
|
Phenotype Submission – Blinding diseases (diabetic retinopathy/diabetic macular edema, age-related macular degeneration, macular edema, and retinal vein occlusion)
|
|
1
|
163
|
August 27, 2023
|
|
Phenotype Submission - new users of 3 monthly intravitreal anti-VEGF (aflibercept, bevacizumab, ranibizumab)
|
|
1
|
150
|
August 27, 2023
|
|
Call for collaborators: Trial Replication Through Observational Study of Yonsei (TROY) Project
|
|
2
|
199
|
August 23, 2023
|
|
Phenotype Submission - Endometriosis
|
|
3
|
370
|
August 23, 2023
|
|
Phenotype Submission - Endometriosis
|
|
4
|
654
|
August 22, 2023
|
|
Denominator cohort for incidence rate analysis
|
|
1
|
221
|
August 22, 2023
|
|
ATLAS Incidence Rate cohort total
|
|
3
|
235
|
August 22, 2023
|
